UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 43

Sortiert nach

3,3'-Diindolylmethane is a novel mitochondrial H(+)-ATP synthase inhibitor that can induce p21(Cip1/Waf1) expression by induction of oxidative stress in human breast cancer cells

Cancer research (Chicago, Ill.), 2006-05, Vol.66 (9), p.4880

2006

Link zum Volltext

Verfügbarkeit prüfen

3,3'-diindolylmethane is a novel mitochondrial H+-ATP synthase inhibitor that can induce p21Cip1/Waf1 expression by induction of oxidative stress in human breast cancer cells

Cancer research (Chicago, Ill.), 2006-05, Vol.66 (9), p.4880-4887

2006

Link zum Volltext

Verfügbarkeit prüfen

3,3'-Diindolylmethane Is a Novel Mitochondrial H super(+)-ATP Synthase Inhibitor that Can Induce p21 super(Cip1/Waf1) Expression by Induction of Oxidative Stress in Human Breast Cancer Cells

Cancer research (Chicago, Ill.), 2006-05, Vol.66 (9), p.4880-4887

2006

Link zum Volltext

Verfügbarkeit prüfen

Abstract 2535: Enhanced gene expression of replication fork and other E2F targets genes is associated with sensitivity and, paradoxically, also with acquired drug resistance, to the Chk1 inhibitor prexasertib

Cancer research (Chicago, Ill.), 2019-07, Vol.79 (13_Supplement), p.2535-2535

2019

Link zum Volltext

Verfügbarkeit prüfen

Abstract 282: Pan-RAF inhibitor LY3009120 sensitizes RAS or BRAF mutant cancer to CDK4 and 6 inhibition by abemaciclib via superior inhibition of phospho-RB and suppression of cyclin D1

Cancer research (Chicago, Ill.), 2016-07, Vol.76 (14_Supplement), p.282-282

2016

Link zum Volltext

Verfügbarkeit prüfen

Abstract 2874: Resolving an immune tolerogenic niche at the earliest phase of oral cancer initiation

Cancer research (Chicago, Ill.), 2023-04, Vol.83 (7_Supplement), p.2874-2874

2023

Link zum Volltext

Verfügbarkeit prüfen

Abstract 342: Development and characterization of a novel anti-CLDN6 antibody drug conjugate for the treatment of CLDN6 positive cancers

Cancer research (Chicago, Ill.), 2022-06, Vol.82 (12_Supplement), p.342-342

2022

Link zum Volltext

Verfügbarkeit prüfen

Abstract 4391: CD20 as a target for therapy in solid tumors

Cancer research (Chicago, Ill.), 2012-04, Vol.72 (8_Supplement), p.4391-4391

2012

Link zum Volltext

Verfügbarkeit prüfen

Abstract 472: Tumor DNA methylation and microRNA expression in breast cancer among American women of African or European ancestry

Cancer research (Chicago, Ill.), 2018-07, Vol.78 (13_Supplement), p.472-472

2018

Link zum Volltext

Verfügbarkeit prüfen

Abstract 5318: Optimizing pharmacokinetics and targeting properties of recombinant anti-Lewis Y antibody hu3S193 in A431 tumor-bearing mice

Cancer research (Chicago, Ill.), 2011-04, Vol.71 (8_Supplement), p.5318-5318

2011

Link zum Volltext

Verfügbarkeit prüfen

Abstract 5328: Intergenic DNA methylation differences in ER- breast tumors from African American versus European American women

Cancer research (Chicago, Ill.), 2018-07, Vol.78 (13_Supplement), p.5328-5328

2018

Link zum Volltext

Verfügbarkeit prüfen

Abstract LB-101: Targeting pancreatic cancer stroma with Palmatine, a novel compound from herbal supplement

Cancer research (Chicago, Ill.), 2013-04, Vol.73 (8_Supplement), p.LB-101-LB-101

2013

Link zum Volltext

Verfügbarkeit prüfen

Abstract OT2-16-05: Safety Analyses of NRG BR004: A Randomized, Double-blind, Phase III Trial of Taxane/Trastuzumab/Pertuzumab with Atezolizumab or Placebo in First-line HER2-Positive Metastatic Breast Cancer (MBC)

Cancer research (Chicago, Ill.), 2023-03, Vol.83 (5_Supplement), p.OT2-16-05-OT2-16-05

2023

Link zum Volltext

Verfügbarkeit prüfen

Abstract P1-08-25: Withdrawn

Cancer research (Chicago, Ill.), 2019-02, Vol.79 (4_Supplement), p.P1-P1-08-25

2019

Link zum Volltext

Verfügbarkeit prüfen

Abstract P1-24-02: Genetic variants and tumor microenvironment in inflammatory breast cancer: Clues for targeted therapies

Cancer research (Chicago, Ill.), 2022-02, Vol.82 (4_Supplement), p.P1-P1-24-02

2022

Link zum Volltext

Verfügbarkeit prüfen

Abstract P2-06-13: Pathway Profiling of Signal Transduction Proteins in Paired Tumor and Adjacent Normal Tissues Obtained from Breast Cancer Patients

Cancer research (Chicago, Ill.), 2010-12, Vol.70 (24_Supplement), p.P2-P2-06-13

2010

Link zum Volltext

Verfügbarkeit prüfen

Abstract PD07-03: A Genomic Predictor of Survival Following Taxane-Anthracycline Chemotherapy for Breast Cancer

Cancer research (Chicago, Ill.), 2010-12, Vol.70 (24_Supplement), p.PD07-03-PD07-03

2010

Link zum Volltext

Verfügbarkeit prüfen

Activation of antioxidant pathways in ras-mediated oncogenic transformation of human surface ovarian epithelial cells revealed by functional proteomics and mass spectrometry

Cancer research (Chicago, Ill.), 2004-07, Vol.64 (13), p.4577-4584

2004

Link zum Volltext

Verfügbarkeit prüfen

Association of Proliferating Macrophages with High Grade, Hormone Receptor Negative Breast Cancer

Cancer research (Chicago, Ill.), 2009-12, Vol.69 (24_Supplement), p.3042-3042

2009

Link zum Volltext

Verfügbarkeit prüfen

Breast Cancer Initiating Cells Promote Chemoresistance by Pre-Activation of the DNA Damage Repair

Cancer research (Chicago, Ill.), 2009-12, Vol.69 (24_Supplement), p.1121-1121

2009

Link zum Volltext

Verfügbarkeit prüfen

Caffeine prevents apoptosis and cell cycle effects induced by camptothecin or topotecan in HL-60 cells

Cancer research (Chicago, Ill.), 1993-10, Vol.53 (19), p.4613-4618

1993

Link zum Volltext

Verfügbarkeit prüfen

The cell cycle related differences in susceptibility of HL-60 cells to apoptosis induced by various antitumor agents

Cancer research (Chicago, Ill.), 1993-07, Vol.53 (13), p.3186-3192

1993

Link zum Volltext

Verfügbarkeit prüfen

Circulating Glioma Cells Exhibit Stem Cell-like Properties

Cancer research (Chicago, Ill.), 2018-12, Vol.78 (23), p.6632-6642

2018

Link zum Volltext

Verfügbarkeit prüfen

Evaluation of microtubule associated protein tau expression as prognostic and predictive marker in the NSABP-B 28 randomized clinical trial

Cancer research (Chicago, Ill.), 2009-01, Vol.69 (2_Supplement), p.54

2009

Link zum Volltext

Verfügbarkeit prüfen

FoxM1 Drives a Feed-Forward STAT3-Activation Signaling Loop That Promotes the Self-Renewal and Tumorigenicity of Glioblastoma Stem-like Cells

Cancer research (Chicago, Ill.), 2015-06, Vol.75 (11), p.2337-2348

2015

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 43

Suche als RSS-Feed

Aktive Filter

ThemaMaterials Science

Zeitschrift / SerieCancer Research

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(43)
Mit Volltextzugriff
(43)

Publikationsform

Artikel
(43)

Sprache

Englisch
(43)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

Humans
(15)
Life Sciences & Biomedicine
(15)
Oncology
(15)
Science & Technology
(15)
Biological And Medical Sciences
(13)
Medical Sciences
(12)
Antineoplastic Agents
(8)
Pharmacology. Drug Treatments
(8)
Tumors
(8)
Female
(6)
General Aspects
(6)
Animals
(5)
Cell Cycle - Drug Effects
(5)
Mice
(5)
Tumor Cells, Cultured
(5)
Apoptosis - Drug Effects
(4)
Cell Line, Tumor
(4)
Dna, Neoplasm - Analysis
(4)
Gynecology. Andrology. Obstetrics
(4)
Antineoplastic Agents - Pharmacology
(3)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

Menü

Weitere Dienste

Einstellungen

3,3'-Diindolylmethane is a novel mitochondrial H(+)-ATP synthase inhibitor that can induce p21(Cip1/Waf1) expression by induction of oxidative stress in human breast cancer cells

3,3'-diindolylmethane is a novel mitochondrial H+-ATP synthase inhibitor that can induce p21Cip1/Waf1 expression by induction of oxidative stress in human breast cancer cells

3,3'-Diindolylmethane Is a Novel Mitochondrial H super(+)-ATP Synthase Inhibitor that Can Induce p21 super(Cip1/Waf1) Expression by Induction of Oxidative Stress in Human Breast Cancer Cells

Abstract 2535: Enhanced gene expression of replication fork and other E2F targets genes is associated with sensitivity and, paradoxically, also with acquired drug resistance, to the Chk1 inhibitor prexasertib

Abstract 282: Pan-RAF inhibitor LY3009120 sensitizes RAS or BRAF mutant cancer to CDK4 and 6 inhibition by abemaciclib via superior inhibition of phospho-RB and suppression of cyclin D1

Abstract 2874: Resolving an immune tolerogenic niche at the earliest phase of oral cancer initiation

Abstract 342: Development and characterization of a novel anti-CLDN6 antibody drug conjugate for the treatment of CLDN6 positive cancers

Abstract 4391: CD20 as a target for therapy in solid tumors

Abstract 472: Tumor DNA methylation and microRNA expression in breast cancer among American women of African or European ancestry

Abstract 5318: Optimizing pharmacokinetics and targeting properties of recombinant anti-Lewis Y antibody hu3S193 in A431 tumor-bearing mice

Abstract 5328: Intergenic DNA methylation differences in ER- breast tumors from African American versus European American women

Abstract LB-101: Targeting pancreatic cancer stroma with Palmatine, a novel compound from herbal supplement

Abstract OT2-16-05: Safety Analyses of NRG BR004: A Randomized, Double-blind, Phase III Trial of Taxane/Trastuzumab/Pertuzumab with Atezolizumab or Placebo in First-line HER2-Positive Metastatic Breast Cancer (MBC)

Abstract P1-08-25: Withdrawn

Abstract P1-24-02: Genetic variants and tumor microenvironment in inflammatory breast cancer: Clues for targeted therapies

Abstract P2-06-13: Pathway Profiling of Signal Transduction Proteins in Paired Tumor and Adjacent Normal Tissues Obtained from Breast Cancer Patients

Abstract PD07-03: A Genomic Predictor of Survival Following Taxane-Anthracycline Chemotherapy for Breast Cancer

Activation of antioxidant pathways in ras-mediated oncogenic transformation of human surface ovarian epithelial cells revealed by functional proteomics and mass spectrometry

Association of Proliferating Macrophages with High Grade, Hormone Receptor Negative Breast Cancer

Breast Cancer Initiating Cells Promote Chemoresistance by Pre-Activation of the DNA Damage Repair

Caffeine prevents apoptosis and cell cycle effects induced by camptothecin or topotecan in HL-60 cells

The cell cycle related differences in susceptibility of HL-60 cells to apoptosis induced by various antitumor agents

Circulating Glioma Cells Exhibit Stem Cell-like Properties

Evaluation of microtubule associated protein tau expression as prognostic and predictive marker in the NSABP-B 28 randomized clinical trial

FoxM1 Drives a Feed-Forward STAT3-Activation Signaling Loop That Promotes the Self-Renewal and Tumorigenicity of Glioblastoma Stem-like Cells

Aktive Filter

Suchergebnisse filtern